Isometric tension and mutant myosin heavy chain content in single skeletal myofibers from hypertrophic cardiomyopathy patients

Journal of Molecular and Cellular Cardiology

Volumn 29, Issue 2, 1997, Pages 667-676

  Malinchik, Sergey ^a   Cuda, Giovanni ^b,d   Podolsky, Richard J ^a   Horowits, Robert ^a,c  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^b NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^c NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES   (United States)

^d UNIVERSITY MEDITERRANEA OF REGGIO CALABRIA   (Italy)

Author keywords

Hypertrophic cardiomyopathy; Molecular genetics; Muscle contraction; Mutation; Myosin

Indexed keywords

MUTANT PROTEIN; MYOSIN HEAVY CHAIN;

AMINO ACID SUBSTITUTION; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; GENE MUTATION; GENOTYPE; HUMAN; HUMAN TISSUE; HYPERTROPHIC CARDIOMYOPATHY; MUSCLE ISOMETRIC CONTRACTION; PRIORITY JOURNAL; SKELETAL MUSCLE; SLOW MUSCLE FIBER;

EID: 0031080060     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1006/jmcc.1996.0309     Document Type: Article

References (59)

1. AL-MAHDAWI S, CHAMBERLAIN S, CHOJNOWSKA L, MICHALAK E, NIHOYANNOPOULOS P, RYAN M, KUSNIERCZYK B, FRENCH JA, GILLIGAN DM, CLELAND J, WILLIAMSON R, RUZYLLO W, OAKLEY C, 1994. The electrocardiogram is a more sensitive indicator than echocardiography of hypertrophic cardiomyopathy in families with a mutation in the MYH7 gene. Br Heart J 72: 105-111.
2. AL-MAHDAWI S, CHAMBERLAIN S, CLELAND J, NIHOYANNOPOULOS P, GILLIGAN D, FRENCH J, CHOUDHURY L, WILLIAMSON R, OAKLEY C, 1993. Identification of a mutation in the beta cardiac myosin heavy chain gene in a family with hypertrophic cardiomyopathy. Br Heart J 69: 136-141.
3. ANAN R, GREVE G, THIERFELDER L, WATKINS H, MCKENNA WJ, SOLOMON S, VECCHIO C, SHONO H, NAKAO S, TANAKA H, MARES A JR, TOWBIN JA, SPIRITO P, ROBERTS R, SEIDMAN JG, SEIDMAN CE, 1994. Prognostic implications of novel beta cardiac myosin heavy chain gene mutations that cause familial hypertrophic cardiomyopathy. J Clin Invest 93: 280-285.
4. APRIL EW, BRANDT PW, ELLIOTT GF, 1971. The myofilament lattice: studies on isolated fibers. I. The constancy of the unit-cell volume with variation in sarcomere length in a lattice in which the thin-to-thick myofilament ratio is 6:1. J Cell Biol 51: 72-82.
5. BONNE G, CARRIER L, BERCOVICI J, CRUAUD C, RICHARD P, HAINQUE B, GAUTEL M, LABEIT S, JAMES M, BECKMANN J, WEISSENBACH J, VOSBERG HP, FISZMAN M, KOMAJDA M, SCHWARTZ K, 1995. Cardiac myosin binding protein-C gene splice acceptor site mutation is associated with familial hypertrophic cardiomyopathy. Nat Genet 11: 438-440.
6. CONSEVAGE MW, SALADA GC, BAYLEN BG, LADDA RL, ROGAN PK, 1994. A new missense mutation, Arg-719Gln, in the beta-cardiac heavy chain myosin gene of patients with familial hypertrophic cardiomyopathy. Hum Mol Genet 3: 1025-1026.
7. COVIELLO D, SPIRITO P, BOBOLA N, BERTORELLI R, VECCHIO C, SEIDMAN CE, RAVAZZOLO R, 1993. Analysis of the prevalence of 7 cardiac myosin heavy chain gene mutations in 13 Italian families with hypertrophic cardiomyopathy. J Am Coll Cardiol 21: 100A.
8. CUDA G, FANANAPAZIR L, ZHU WS, SELLERS JR, EPSTEIN ND, 1993. Skeletal muscle expression and abnormal function of beta-myosin in hypertrophic cardiomyopathy. J Clin Invest 91: 2861-2865.
9. DAUSSE E, KOMAJDA M, FETLER L, DUBOURG O, DUFOUR C, CARRIER L, WISNEWSKY C, BERCOVICI J, HENGSTENBERG C, AL-MAHDAWI S, ISNARD R, HAGEGE A, BOUHOUR JB, DESNOS M, BECKMANN J, WEISSENBACH J, SCHWARTZ K, GUICHENEY P, 1993. Familial hypertrophic cardiomyopathy. Micro satellite haplotyping and identification of a hot spot for mutations in the beta-myosin heavy chain gene. J Clin Invest 92: 2807-2813.
10. DE LOZANNE A, BERLOT CH, LEINWAND LA, SPUDICH JA, 1987. Expression in Escherichia coli of a functional Dictyostelium myosin tail fragment. J Cell Biol 105: 2999-3005.
11. DUFOUR C, DAUSSE E, FETLER L, DUBOURG O, BOUHOUR JB, VOSBERG HP, GUICHENEY P, KOMAJDA M, SCHWARTZ K, 1994. Identification of a mutation near a functional site of the beta cardiac myosin heavy chain gene in a family with hypertrophic cardiomyopathy. J Mol Cell Cardiol 26: 1241-1247.
12. EDDINGER TJ, MOSS RL, 1987. Mechanical properties of skinned single fibers of identified types from rat diaphragm. Am J Physiol 253: c210-218.
13. Arg→Gln mutation. Circulation 86: 345-352.
14. EPSTEIN ND, FANANAPAZIR L, LIN HJ, MULVIHILL J, WHITE R, LALOUEL JM, LIFTON RP, NIENHUIS AW, LEPPERT M, 1992b. Evidence of genetic heterogeneity in five kindreds with familial hypertrophic cardiomyopathy. Circulation 85: 635-647.
15. FANANAPAZIR L, CHANG AC, EPSTEIN SE, MCAREAVEY D, 1992. Prognostic determinants in hypertrophic cardiomyopathy. Prospective evaluation of a therapeutic strategy based on clinical, Holter, hemodynamic, and electrophysiological findings. Circulation 86: 730-740.
16. FANANAPAZIR L, DALAKAS MC, CYRAN F, COHN G, EPSTEIN ND, 1993. Missense mutations in the beta-myosin heavy-chain gene cause central core disease in hypertrophic cardiomyopathy. Proc Natl Acad Sci USA 90: 3993-3997.
17. FANANAPAZIR L, EPSTEIN ND, 1994. Genotype-phenotype correlations in hypertrophic cardiomyopathy. Insights provided by comparisons of kindreds with distinct and identical beta-myosin heavy chain gene mutations. Circulation 89: 22-32.
18. FANANAPAZIR L, EPSTEIN SE, 1989. VT and sudden death in HCM Patients. Circulation 80: 1923.
19. FANANAPAZIR L, EPSTEIN SE, 1991. Hemodynamic and electrophysiologic evaluation of patients with hypertrophic cardiomyopathy surviving cardiac arrest. Am J Cardiol 67: 280-287.
20. FANANAPAZIR L, MARON BJ, 1990. Arrhythmias in hypertrophic cardiomyopathy. In: Horowitz L (ed.). Current Management of Arrhythmias. BC Decker, Inc.: 182-194.
21. FANANAPAZIR L, TRACY CM, LEON MB, WINKLER JB, CANNON ROD, BONOW RO, MARON BJ, EPSTEIN SE, 1989. Electrophysiologic abnormalities in patients with hypertrophic cardiomyopathy. A consecutive analysis in 155 patients. Circulation 80: 1259-1268.
22. GEISTERFER-LOWRANCE AA, KASS S, TANIGAWA G, VOSBERG HP, MCKENNA W, SEIDMAN CE, SEIDMAN JG, 1990. A molecular basis for familial hypertrophic cardiomyopathy: a beta cardiac myosin heavy chain gene missense mutation. Cell 62: 999-1006.
23. GOLDMAN YE, SIMMONS RM, 1984. Control of sarcomere length in skinned muscle fibres of Rana temporaria during mechanical transients. J Physiol (Lond) 350: 497-518.
24. GREVE G, BACHINSKI L, FRIEDMAN DL, CZERNUZEWICZ G, ANAN R, TOWBIN J, SEIDMAN CE, ROBERTS R, 1994. Isolation of a de novo mutant myocardial beta MHC protein in a pedigree with hypertrophic cardiomyopathy. Hum Mol Genet 3: 2073-2075.
25. HARADA H, KIMURA A, NISHI H, SASAZUKI T, TOSHIMA H, 1993. A missense mutation of cardiac beta-myosin heavy chain gene linked to familial hypertrophic cardiomyopathy in affected Japanese families. Biochem Biophys Res Commun 194: 791-798.
26. HEJTMANCIK JF, BRINK PA, TOWBIN J, HILL R, BRINK L, TAPSCOTT T, TRAKHTENBROIT A, ROBERTS R, 1991. Localization of gene for familial hypertrophic cardiomyopathy to chromosome 14ql in a diverse US population. Circulation 83: 1592-1597.
27. HELLAM DC, PODOLSKY RJ, 1969. Force measurements in skinned muscle fibres. J Physiol (Lond) 200: 807-819.
28. HOROWITS R, KEMPNER ES, BISHER ME, PODOLSKY RJ, 1986. A physiological role for titin and nebulin in skeletal muscle. Nature 323: 160-164.
29. HOROWITS R, PODOLSKY RJ, 1987. The positional stability of thick filaments in activated skeletal muscle depends on sarcomere length: evidence for the role of titin filaments. J Cell Biol 105: 2217-2223.
30. JARCHO JA, MCKENNA W, PARE JA, SOLOMON SD, HOLCOMBE RF, DICKIE S, LEVI T, DONIS-KELLER H, SEIDMAN JG, SEIDMAN CE, 1989. Mapping a gene for familial hypertrophic cardiomyopathy to chromosome 14ql. N Engl J Med 321: 1372-1378.
31. KATO M, TAKAZAWA K, KIMURA A, RUEGG JC, AMANO K, WANG Y, SAKAKI Y, TOYOOKA T, 1995. Altered actin binding with myosin mutation in hypertrophic cardiomyopathy and sudden death. Lancet 345: 1247.
32. KAWAI M, KUNTZ ID, 1973. Optical diffraction studies of muscle fibers. Biophys J 13: 857-876.
33. KIMURA A, NISHI H, HARADA H, NOGUCHI M, ASHIZAWA N, KOGA Y, YANO K, YAZAKI Y, KITABATAKE A, TOSHIMA H, SASAZUKI T, 1994. Genetic analysis of hypertrophic cardiomyopathy. In: Clark EB, Markward RR, Takao A (ed.). Developmental Mechanisms of Heart Disease. New York: Futura, 113-120.
34. LAEMMLI UK, 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227: 680-685.
35. LANKFORD EB, EPSTEIN ND, FANANAPAZIR L, SWEENEY HL, 1995. Abnormal contractile properties of muscle fibers expressing beta-myosin heavy chain gene mutations in patients with hypertrophic cardiomyopathy. J Clin Invest 95: 1409-1414.
36. LOMPRE AM, NADAL-GINARD B, MAHDAVI V, 1984. Expression of the cardiac ventricular alpha-and beta-myosin heavy chain genes is developmentally and hormonally regulated. J Biol Chem 259: 6437-6446.
37. LOWEY S, SLAYTER HS, WEEDS AG, BAKER H, 1969. Substructure of the myosin molecule. I. Subfragments of myosin by enzymic degradation. J Mol Biol 42: 1-29.
38. MARIAN AJ, YU QT, MARES AJ, HILL R, ROBERTS R, PERRYMAN MB, 1992. Detection of a new mutation in the beta-myosin heavy chain gene in an individual with hypertrophic cardiomyopathy. J Clin Invest 90: 2156-2165.
39. MARON BJ, FANANAPAZIR L, 1992. Sudden cardiac death in hypertrophic cardiomyopathy. Circulation 85: i57-63.
40. MOOLMAN JC, BRINK PA, CORFIELD VA, 1993. Identification of a new missense mutation at Arg403, a CpG mutation hotspot, in exon 13 of the beta-myosin heavy chain gene in hypertrophic cardiomyopathy. Hum Mol Genet 2: 1731-1732.
41. NISHI H, KIMURA A, HARADA H, KOGA Y, ADACHI K, MATSUYAMA K, KOYANAGI T, YASUNAGA S, IMAIZUMI T, TOSHIMA H, SASAZUKI T, 1995. A myosin missense mutation, not a null allele, causes familial hypertrophic cardiomyopathy. Circulation 91: 2911-2915.
42. NISHI H, KIMURA A, HARADA H, TOSHIMA H, SASAZUKI T, 1992. Novel missense mutation in cardiac beta myosin heavy chain gene found in a Japanese patient with hypertrophic cardiomyopathy. Biochem Biophys Res Commun 188: 379-387.
43. FERRYMAN MB, YU QT, MARIAN AJ, MARES AJ, CZERNUSZEWICZ G, IFEGWU J, HILL R, ROBERTS R, 1992. Expression of a missense mutation in the messenger RNA for beta-myosin heavy chain in myocardial tissue in hypertrophic cardiomyopathy. J Clin Invest 90: 271-277.
44. RAYMENT I, HOLDEN HM, SELLERS JR, FANANAPAZIR L, EPSTEIN ND, 1995. Structural interpretation of the mutations in the beta-cardiac myosin that have been implicated in familial hypertrophic cardiomyopathy. Proc Natl Acad Sci USA 92: 3864-3868.
45. RAYMENT I, RYPNIEWSKI WR, SCHMIDT-BASE K, SMITH R, TOMCHICK DR, BENNING MM, WINKELMANN DA, WESENBERG G, HOLDEN HM, 1993. Three-dimensional structure of myosin subfragment-1: a molecular motor. Science 261: 50-58.
46. SANDOW A, 1936a. Diffraction patterns of the frog sartorius and sarcomere behavior during contraction. J Cell Comp Physiol 9: 55-75.
47. SANDOW A, 1936b. Diffraction patterns of the frog sartorius and sarcomere behavior under stretch. J Cell Comp Physiol 9: 37-54.
48. SCHWARTZ K, BECKMANN J, DUFOUR C, FAURE L, FOUGEROUSSE F, CARRIER L, HENGSTENBERG C, COHEN D, VOSBERG HP, SACREZ A, FERRIERE M, DESNOS M, CAMBIEN F, DUBOURG O, KOMAJDA M, 1992. Exclusion of cardiac myosin heavy chain and actin gene involvement in hypertrophic cardiomyopathy of several French families. Circ Res 71: 3-8.
49. SINHA AM, FRIEDMAN DJ, NIGRO JM, JAKOVCIC S, RABINOWITZ M, UMEDA PK, 1984. Expression of rabbit ventricular alpha-myosin heavy chain messenger RNA sequences in atrial muscle. J Biol Chem 259: 6674-6680.
50. SNEDECOR GW, COCHRAN WG, 1980. Statistical Methods. The Iowa State University Press, Ames, Iowa.
51. SOLOMON SD, JARCHO JA, MCKENNA W, GEISTERFER-LOWRANCE A, GERMAIN R, SALERNI R, SEIDMAN JG, SEIDMAN CE, 1990. Familial hypertrophic cardiomyopathy is a genetically heterogeneous disease. J Clin Invest 86: 993-999.
52. SOLOMON SD, WOLFF S, WATKINS H, RIDKER PM, COME P, MCKENNA WJ, SEIDMAN CE, LEE RT, 1993. Left ventricular hypertrophy and morphology in familial hypertrophic cardiomyopathy associated with mutations of the beta-myosin heavy chain gene. J Am Coll Cardiol 22: 498-505.
53. THIERFELDER L, WATKINS H, MACRAE C, LAMAS R, MCKENNA W, VOSBERG HP, SEIDMAN JG, SEIDMAN CE, 1994. Alpha-tropomyosin and cardiac troponin T mutations cause familial hypertrophic cardiomyopathy: a disease of the sarcomere. Cell 77: 701-712.
54. WATKINS H, CONNER D, THIERFELDER L, JARCHO JA, MACRAE C, MCKENNA WJ, MARON BJ, SEIDMAN JG, SEIDMAN CE, 1995. Mutations in the cardiac myosin binding protein-C gene on chromosome 11 cause familial hypertrophic cardiomyopathy. Nat Genet 11: 434-437.
55. WATKINS H, ROSENZWEIG A, HWANG DS, LEVI T, MCKENNA W, SEIDMAN CE, SEIDMAN JG, 1992a. Characteristics and prognostic implications of myosin missense mutations in familial hypertrophic cardiomyopathy. N Engl J Med 326: 1108-1114.
56. WATKINS H, THIERFELDER L, ANAN R, JARCHO J, MATSUMORI A, MCKENNA W, SEIDMAN JG, SEIDMAN CE, 1993. Independent origin of identical beta cardiac myosin heavy-chain mutations in hypertrophic cardiomyopathy. Am J Hum Genet 53: 1180-1185.
57. WATKINS H, THIERFELDER L, HWANG DS, MCKENNA W, SEIDMAN JG, SEIDMAN CE, 1992b. Sporadic hypertrophic cardiomyopathy due to de novo myosin mutations. J Clin Invest 90: 1666-1671.
58. WOOD DS, ZOLLMAN J, REUBEN JP, BRANDT PW, 1975. Human skeletal muscle: properties of the "chemically skinned" fiber. Science 187: 1075-1076.
59. YU QT, IFEGWU J, MARIAN AJ, MARES AJ, HILL R, PERRYMAN MB, BACHINSKI LL, ROBERTS R, 1993. Hypertrophic cardiomyopathy mutation is expressed in messenger RNA of skeletal as well as cardiac muscle. Circulation 87: 406-412.